Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Corvus Pharmaceuticals Inc sell tbackenh

Corvus Pharmaceuticals Inc
Start price
€17.52
02.02.26 / 50%
Target price
-
02.03.26
Performance (%)
-12.10%
End price
€15.40
03.03.26
Summary
This prediction ended on 03.03.26 with a price of €15.40. The prediction for Corvus Pharmaceuticals Inc closed with a convincing performance of -12.10%. tbackenh has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Corvus Pharmaceuticals Inc -12.951% -12.951%
iShares Core DAX® -3.520% -4.987%
iShares Nasdaq 100 0.261% 1.102%
iShares Nikkei 225® -4.953% -3.352%
iShares S&P 500 -0.823% -0.042%

According to tbackenh what are the pros and cons of Corvus Pharmaceuticals Inc for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Innovative
positive Cash Flow expected
Normal challenges to pay loans and raise capital
Cons
High valuation
Very low/no dividend yield expected
Lower EBIT Margin than peer group
Higher risks for its business

Comments by tbackenh for this prediction

In the thread Trading Corvus Pharmaceuticals Inc
Prediction Sell
Perf. (%) -12.10%
Target price
Change
Ends at 02.03.26

Die von tbackenh gewählte maximale Laufzeit wurde überschritten

tbackenh 
0
Report Share
03.03.26

Stopped prediction by tbackenh for Corvus Pharmaceuticals Inc

sell
Corvus Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€5.20
20.09.21
€4.00
20.09.22
-22.69%
22.10.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Innovative
High valuation
tbackenh 
20.09.21 60%